Heron Therapeutics Inc (NASDAQ:HRTX) shares, rose in value, with the stock price down by -5.36% to the previous day’s close as strong demand from buyers drove the stock to $2.65.
Actively observing the price movement in the last trading, the stock closed the session at $2.80. Referring to stock’s 52-week performance, its high was $3.22, and the low was $0.50. On the whole, HRTX has fluctuated by -10.17% over the past month.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that HRTX’s technical picture suggests that short-term indicators denote the stock is a 25% Buy on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of HRTX currently trading nearly -3.50% and -3.49% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 45.91, while the 7-day volatility ratio is showing 9.81% which for the 30-day chart, stands at 7.48%. Furthermore, Heron Therapeutics Inc (HRTX)’s beta value is 1.69, and its average true range (ATR) is 0.22.
A comparison of Heron Therapeutics Inc (HRTX) with its peers suggests the former has fared considerably weaker in the market. HRTX showed an intraday change of -5.36% in last session, and over the past year, it shrunk by -0.38%%.
Data on historical trading for Heron Therapeutics Inc (NASDAQ:HRTX) indicates that the trading volumes over the past 3 months, they’ve averaged 2.58 million. According to company’s latest data on outstanding shares, there are 150.29 million shares outstanding.
Nearly 5.08% of Heron Therapeutics Inc’s shares belong to company insiders and institutional investors own 71.16% of the company’s shares. The stock has risen by 55.88% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the HRTX stock heading into the next quarter.
